Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons
The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracel...
Gespeichert in:
Veröffentlicht in: | Neuroscience research 1999-12, Vol.35 (4), p.299-307 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 307 |
---|---|
container_issue | 4 |
container_start_page | 299 |
container_title | Neuroscience research |
container_volume | 35 |
creator | Otoom, Sameer A Alkadhi, Karim A |
description | The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracellular techniques. Large concentrations of VPA (5 mM or more) enhanced rather than inhibited epileptiform activity induced by veratridine. During the proepileptic phase of VPA, a membrane depolarization accompanied by a decrease in membrane input resistance were evident. The voltage-dependent proepileptic effect of VPA was blocked by tetrodotoxin (TTX; 100 nM) but not by the calcium channel blockers, diltiazem (5 μM) or ω-conotoxin GVIA (5 μM). VPA did not induce a proepileptic effect when it was superfused at high concentration (0.5–10 mM) on sodium channel-independent models such as the bicuculline or magnesium-free artificial cerebrospinal fluid. Large concentrations of VPA had no significant effect on untreated neurons. The VPA-enhanced veratridine bursting is probably related to the reported proepileptic activities observed in patients taking high doses of this drug. These data also suggest the involvement of sodium channels in the proepileptic effect of VPA. |
doi_str_mv | 10.1016/S0168-0102(99)00099-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69385497</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168010299000991</els_id><sourcerecordid>69385497</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-23c623d2b8c55a54fa2056c1f39ce2a2e304c3330c275b65d5b08964be95fbb33</originalsourceid><addsrcrecordid>eNqFkEtLw0AQgBdRbK3-BCUn0UN0H9k0exIpvqDgwep12WwmdCQvd5NC_73bRsSbl5mB-WaG-Qg5Z_SGUZbevoWQxZRRfqXUNaVUqZgdkCnL5jzOGGOHZPqLTMiJ958BEioRx2TCaMrmgrMpWX2YqnMt2shYLCJsemg8lgg-gg4r6HosW1eHbo8b7LeBiPo1RGvsutaaujNV1G2dqbEIVQODaxt_So5KU3k4-8kz8v74sFo8x8vXp5fF_TK2QtE-5sKmXBQ8z6yURial4VSmlpVCWeCGg6CJFUJQy-cyT2Uhc5qpNMlByTLPhZiRy3Fv-OBrAN_rGr2FqjINtIPXqRKZTNQ8gHIErWu9d1DqzmFt3FYzqnc69V6n3rnSSum9Ts3C3MXPgSGvofgzNfoLwN0IQHhzg-C0twiNhQId2F4XLf5z4hv144WE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69385497</pqid></control><display><type>article</type><title>Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Otoom, Sameer A ; Alkadhi, Karim A</creator><creatorcontrib>Otoom, Sameer A ; Alkadhi, Karim A</creatorcontrib><description>The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracellular techniques. Large concentrations of VPA (5 mM or more) enhanced rather than inhibited epileptiform activity induced by veratridine. During the proepileptic phase of VPA, a membrane depolarization accompanied by a decrease in membrane input resistance were evident. The voltage-dependent proepileptic effect of VPA was blocked by tetrodotoxin (TTX; 100 nM) but not by the calcium channel blockers, diltiazem (5 μM) or ω-conotoxin GVIA (5 μM). VPA did not induce a proepileptic effect when it was superfused at high concentration (0.5–10 mM) on sodium channel-independent models such as the bicuculline or magnesium-free artificial cerebrospinal fluid. Large concentrations of VPA had no significant effect on untreated neurons. The VPA-enhanced veratridine bursting is probably related to the reported proepileptic activities observed in patients taking high doses of this drug. These data also suggest the involvement of sodium channels in the proepileptic effect of VPA.</description><identifier>ISSN: 0168-0102</identifier><identifier>EISSN: 1872-8111</identifier><identifier>DOI: 10.1016/S0168-0102(99)00099-1</identifier><identifier>PMID: 10617321</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Action Potentials - drug effects ; Action Potentials - physiology ; Animals ; Bicuculline ; Bicuculline - pharmacology ; Disease Models, Animal ; Epilepsy - physiopathology ; GABA Antagonists - pharmacology ; Hippocampus ; Hippocampus - drug effects ; Hippocampus - physiopathology ; Magnesium-free artificial cerebrospinal fluid (ACSF) ; Male ; Proepileptic ; Pyramidal Cells - drug effects ; Pyramidal Cells - physiopathology ; Rats ; Rats, Sprague-Dawley ; Sodium Channels - drug effects ; Sodium Channels - physiology ; Valproic acid ; Valproic Acid - pharmacology ; Veratridine</subject><ispartof>Neuroscience research, 1999-12, Vol.35 (4), p.299-307</ispartof><rights>1999 Elsevier Science Ireland Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-23c623d2b8c55a54fa2056c1f39ce2a2e304c3330c275b65d5b08964be95fbb33</citedby><cites>FETCH-LOGICAL-c390t-23c623d2b8c55a54fa2056c1f39ce2a2e304c3330c275b65d5b08964be95fbb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0168-0102(99)00099-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10617321$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Otoom, Sameer A</creatorcontrib><creatorcontrib>Alkadhi, Karim A</creatorcontrib><title>Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons</title><title>Neuroscience research</title><addtitle>Neurosci Res</addtitle><description>The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracellular techniques. Large concentrations of VPA (5 mM or more) enhanced rather than inhibited epileptiform activity induced by veratridine. During the proepileptic phase of VPA, a membrane depolarization accompanied by a decrease in membrane input resistance were evident. The voltage-dependent proepileptic effect of VPA was blocked by tetrodotoxin (TTX; 100 nM) but not by the calcium channel blockers, diltiazem (5 μM) or ω-conotoxin GVIA (5 μM). VPA did not induce a proepileptic effect when it was superfused at high concentration (0.5–10 mM) on sodium channel-independent models such as the bicuculline or magnesium-free artificial cerebrospinal fluid. Large concentrations of VPA had no significant effect on untreated neurons. The VPA-enhanced veratridine bursting is probably related to the reported proepileptic activities observed in patients taking high doses of this drug. These data also suggest the involvement of sodium channels in the proepileptic effect of VPA.</description><subject>Action Potentials - drug effects</subject><subject>Action Potentials - physiology</subject><subject>Animals</subject><subject>Bicuculline</subject><subject>Bicuculline - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Epilepsy - physiopathology</subject><subject>GABA Antagonists - pharmacology</subject><subject>Hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - physiopathology</subject><subject>Magnesium-free artificial cerebrospinal fluid (ACSF)</subject><subject>Male</subject><subject>Proepileptic</subject><subject>Pyramidal Cells - drug effects</subject><subject>Pyramidal Cells - physiopathology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sodium Channels - drug effects</subject><subject>Sodium Channels - physiology</subject><subject>Valproic acid</subject><subject>Valproic Acid - pharmacology</subject><subject>Veratridine</subject><issn>0168-0102</issn><issn>1872-8111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLw0AQgBdRbK3-BCUn0UN0H9k0exIpvqDgwep12WwmdCQvd5NC_73bRsSbl5mB-WaG-Qg5Z_SGUZbevoWQxZRRfqXUNaVUqZgdkCnL5jzOGGOHZPqLTMiJ958BEioRx2TCaMrmgrMpWX2YqnMt2shYLCJsemg8lgg-gg4r6HosW1eHbo8b7LeBiPo1RGvsutaaujNV1G2dqbEIVQODaxt_So5KU3k4-8kz8v74sFo8x8vXp5fF_TK2QtE-5sKmXBQ8z6yURial4VSmlpVCWeCGg6CJFUJQy-cyT2Uhc5qpNMlByTLPhZiRy3Fv-OBrAN_rGr2FqjINtIPXqRKZTNQ8gHIErWu9d1DqzmFt3FYzqnc69V6n3rnSSum9Ts3C3MXPgSGvofgzNfoLwN0IQHhzg-C0twiNhQId2F4XLf5z4hv144WE</recordid><startdate>19991230</startdate><enddate>19991230</enddate><creator>Otoom, Sameer A</creator><creator>Alkadhi, Karim A</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991230</creationdate><title>Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons</title><author>Otoom, Sameer A ; Alkadhi, Karim A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-23c623d2b8c55a54fa2056c1f39ce2a2e304c3330c275b65d5b08964be95fbb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Action Potentials - drug effects</topic><topic>Action Potentials - physiology</topic><topic>Animals</topic><topic>Bicuculline</topic><topic>Bicuculline - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Epilepsy - physiopathology</topic><topic>GABA Antagonists - pharmacology</topic><topic>Hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - physiopathology</topic><topic>Magnesium-free artificial cerebrospinal fluid (ACSF)</topic><topic>Male</topic><topic>Proepileptic</topic><topic>Pyramidal Cells - drug effects</topic><topic>Pyramidal Cells - physiopathology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sodium Channels - drug effects</topic><topic>Sodium Channels - physiology</topic><topic>Valproic acid</topic><topic>Valproic Acid - pharmacology</topic><topic>Veratridine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Otoom, Sameer A</creatorcontrib><creatorcontrib>Alkadhi, Karim A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Otoom, Sameer A</au><au>Alkadhi, Karim A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons</atitle><jtitle>Neuroscience research</jtitle><addtitle>Neurosci Res</addtitle><date>1999-12-30</date><risdate>1999</risdate><volume>35</volume><issue>4</issue><spage>299</spage><epage>307</epage><pages>299-307</pages><issn>0168-0102</issn><eissn>1872-8111</eissn><abstract>The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracellular techniques. Large concentrations of VPA (5 mM or more) enhanced rather than inhibited epileptiform activity induced by veratridine. During the proepileptic phase of VPA, a membrane depolarization accompanied by a decrease in membrane input resistance were evident. The voltage-dependent proepileptic effect of VPA was blocked by tetrodotoxin (TTX; 100 nM) but not by the calcium channel blockers, diltiazem (5 μM) or ω-conotoxin GVIA (5 μM). VPA did not induce a proepileptic effect when it was superfused at high concentration (0.5–10 mM) on sodium channel-independent models such as the bicuculline or magnesium-free artificial cerebrospinal fluid. Large concentrations of VPA had no significant effect on untreated neurons. The VPA-enhanced veratridine bursting is probably related to the reported proepileptic activities observed in patients taking high doses of this drug. These data also suggest the involvement of sodium channels in the proepileptic effect of VPA.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>10617321</pmid><doi>10.1016/S0168-0102(99)00099-1</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-0102 |
ispartof | Neuroscience research, 1999-12, Vol.35 (4), p.299-307 |
issn | 0168-0102 1872-8111 |
language | eng |
recordid | cdi_proquest_miscellaneous_69385497 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Action Potentials - drug effects Action Potentials - physiology Animals Bicuculline Bicuculline - pharmacology Disease Models, Animal Epilepsy - physiopathology GABA Antagonists - pharmacology Hippocampus Hippocampus - drug effects Hippocampus - physiopathology Magnesium-free artificial cerebrospinal fluid (ACSF) Male Proepileptic Pyramidal Cells - drug effects Pyramidal Cells - physiopathology Rats Rats, Sprague-Dawley Sodium Channels - drug effects Sodium Channels - physiology Valproic acid Valproic Acid - pharmacology Veratridine |
title | Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T18%3A06%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Valproic%20acid%20intensifies%20epileptiform%20activity%20in%20the%20hippocampal%20pyramidal%20neurons&rft.jtitle=Neuroscience%20research&rft.au=Otoom,%20Sameer%20A&rft.date=1999-12-30&rft.volume=35&rft.issue=4&rft.spage=299&rft.epage=307&rft.pages=299-307&rft.issn=0168-0102&rft.eissn=1872-8111&rft_id=info:doi/10.1016/S0168-0102(99)00099-1&rft_dat=%3Cproquest_cross%3E69385497%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69385497&rft_id=info:pmid/10617321&rft_els_id=S0168010299000991&rfr_iscdi=true |